| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | Jeffrey W. Albers | Director | Oct 13, 2025 | Option/RSU Exercise | $10.34 | 5,000 | 51,700 | 5,000 | Oct 14, 2025, 07:55 AM | |
| KYMR | Kymera Therapeutics, Inc. | Jeffrey W. Albers | Director | Oct 13, 2025 | Sale | $59.19 | 5,000 | 295,949 | 0 | Oct 14, 2025, 07:55 AM | |
| KYMR | Kymera Therapeutics, Inc. | Jeffrey W. Albers | Director | Jun 03, 2025 | Option/RSU Exercise | $10.34 | 6,349 | 65,649 | 6,349 | Jun 03, 2025, 06:30 PM | |
| KYMR | Kymera Therapeutics, Inc. | Jeffrey W. Albers | Director | Jun 03, 2025 | Sale | $49.00 | 6,349 | 311,101 | 0 | Jun 03, 2025, 06:30 PM | |
| SYRE | Spyre Therapeutics, Inc. | Jeffrey W. Albers | Director | Nov 06, 2024 | Sale | $36.76 | 6,700 | 246,313 | 27,360 | Nov 08, 2024, 04:53 PM | |
| SYRE | Spyre Therapeutics, Inc. | Jeffrey W. Albers | Director | Oct 25, 2024 | Sale | $36.43 | 300 | 10,929 | 34,060 | Oct 28, 2024, 04:41 PM | |
| KYMR | Kymera Therapeutics, Inc. | Jeffrey W. Albers | Director | Aug 26, 2024 | Sale | $49.10 | 5,000 | 245,508 | 0 | Aug 26, 2024, 06:31 PM | |
| KYMR | Kymera Therapeutics, Inc. | Jeffrey W. Albers | Director | Aug 26, 2024 | Option/RSU Exercise | $10.34 | 5,000 | 51,700 | 5,000 | Aug 26, 2024, 06:31 PM | |
| KYMR | Kymera Therapeutics, Inc. | Jeffrey W. Albers | Director | Feb 20, 2024 | Option/RSU Exercise | $10.34 | 615 | 6,359 | 615 | Feb 21, 2024, 06:46 PM | |
| KYMR | Kymera Therapeutics, Inc. | Jeffrey W. Albers | Director | Feb 20, 2024 | Sale | $39.07 | 615 | 24,031 | 0 | Feb 21, 2024, 06:46 PM | |
| KYMR | Kymera Therapeutics, Inc. | Jeffrey W. Albers | Director | Feb 21, 2024 | Option/RSU Exercise | $10.34 | 4,385 | 45,341 | 4,385 | Feb 21, 2024, 06:46 PM | |
| KYMR | Kymera Therapeutics, Inc. | Jeffrey W. Albers | Director | Feb 21, 2024 | Sale | $39.05 | 4,385 | 171,227 | 0 | Feb 21, 2024, 06:46 PM | |
| KYMR | Kymera Therapeutics, Inc. | Jeffrey W. Albers | Director | Jan 23, 2024 | Sale | $30.05 | 10,000 | 300,470 | 0 | Jan 23, 2024, 07:37 PM | |
| KYMR | Kymera Therapeutics, Inc. | Jeffrey W. Albers | Director | Jan 23, 2024 | Option/RSU Exercise | $10.34 | 10,000 | 103,400 | 10,000 | Jan 23, 2024, 07:37 PM | |
| SYRE | Spyre Therapeutics, Inc. | Jeffrey W. Albers | Director | Nov 24, 2023 | Conversion | - | 34,360 | - | 34,360 | Dec 08, 2023, 04:07 PM | |
| MGTA | Magenta Therapeutics, Inc. | Jeffrey W. Albers | Director | Jun 25, 2018 | Conversion | - | 4,152 | - | 4,152 | Jun 27, 2018, 04:27 PM |